Clinical evidence indicates that Bacillus Calmette-Guérin (BCG) vaccination exerts anti-
inflammatory effects in diseases such as asthma, multiple sclerosis or Type 1 diabetes …

ABSTRACT Introduction: Bacillus Calmette-Guérin (BCG) is the only available vaccine
against tuberculosis. Although its protective efficacy against pulmonary tuberculosis is still …

Several clinical observations have shown that Bacillus Calmette-Guérin (BCG) vaccine has
beneficial impact on patients suffering from different chronic inflammatory diseases. Here we …

Purpose Bacillus Calmette-Guérin (BCG) is known to suppress the asthmatic responses in a
murine model of asthma and to induce dendritic cells (DCs) maturation. Mature DCs play a …

Most of the evidence available to date suggests a need for an improved mycobacterial
vaccine administered early in life, by means of alternative routes, preferentially mucosal. As …

We have previously shown that bacillus Calmette-Guérin (BCG) inactivated by extended
freeze-drying (EFD) reduces airway hyperresponsiveness, whereas live and heat-killed …

The bacillus Calmette–Guérin (BCG) is an attenuated bacterium derived from virulent
Mycobacterium bovis. It is the only licensed vaccine used for preventing severe forms of …

Allergic diseases such as atopic dermatitis and asthma develop as a consequence of
dysregulated Th2 responses. Recently, it has been demonstrated that interaction between …

Abstract The Bacillus Calmette-Guérin (BCG) vaccine was discovered a century ago and
has since been clinically applicable. BCG can not only be used for the prevention of …

Allergic diseases, in particular atopic asthma, have been on the rise in most industrialized
countries for several decades now. Allergic asthma is characterized by airway narrowing …